Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Caspofungin for the Treatment of Non-blood Candida Infections Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Caspofungin for the Treatment of Non-blood Candida Infections conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Caspofungin for the Treatment of Non-blood Candida Infections Clinical research trials and Caspofungin for the Treatment of Non-blood Candida Infections medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Caspofungin for the Treatment of Non-blood Candida Infections. Caspofungin for the Treatment of Non-blood Candida Infections Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Caspofungin for the Treatment of Non-blood Candida Infections clinical trial. Subjects typically recieve the finest healthcare available for their Caspofungin for the Treatment of Non-blood Candida Infections condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.

Home > "C" Clinical Trials Conditions > Caspofungin for the Treatment of Non-blood Candida Infections

Caspofungin for the Treatment of Non-blood Candida Infections



Caspofungin for the Treatment of Non-blood Candida Infections

For Condition: Candidiasis
Status: Not yet recruiting
Sponsor(s): Sponsor Name Pending ,
Synopsis: Candida is the most common fungal pathogen identified in hospitalized patients. This study will seek to enroll adult patients (18 years of age or older) with invasive Candida infections (involving deep tissues and organs). The study will not enroll patients whose only site of Candida infection was the bloodstream. Patients that fulfill all study entry criteria will receive a single daily dose of caspofungin. Caspofungin, an intravenous echinocandin antifungal agent, is already approved for the treatment of invasive candidiasis. The dosage strength and duration of caspofungin will be individualized for each patient based on disease, severity of diease and extent of infection.
Details:
Eligibility:
Study Type:  Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - All patients must have at least 1 positive culture for Candida species obtained from an otherwise sterile, non-blood body site within 96 hours of the study entry. - The patient must also have clinical evidence of Candida infection (e.g., oral temperature >100 degrees Farenheit, signs of inflammation from infected site, systolic blood presure <90) within 96 hours of study entry. - The patient must be at least 18 years old, and if a woman of child bearing potential, must have a negative serum or urine pregnancy test sensitive to 25 IU HCG prior to enrollment. Exclusion Criteria: - Patients whose only site of Candida infection was the bloodstream.
Total Enrollment: 

Location and Contact Information:


Additional Information:
Study ID Numbers:  0404NBCI; 
Study Start Date: 
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00083343

Other Candidiasis Studies:
1. The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)

2. Caspofungin for the Treatment of Non-blood Candida Infections

3. Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients

4. Fluconazole Prophylaxis of Thrush in AIDS

5. Anidulafungin versus Fluconazole in the Treatment of Candidemia

Related Studies:

Other Candidiasis Clinical Trials
Other Clinical Trials
Other Clinical Trials

Caspofungin for the Treatment of Non-blood Candida Infections
Modify your Search

  Other Candidiasis Clinical Trials
  Other Clinical Trials
  Other Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103